Levemir

Type: Product
Name: Levemir
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

FDA Gives “Tentative Approval” to BI/Lilly’s insulin glargine Basaglar – Full Approval Pending Lawsuit with Sanofi

Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in futureOn August 18, Eli Lilly and Boehringer Ingelheim (BI) announced that the FDA granted “tentative approval” to Basaglar ... [Published diaTribe - Aug 29 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Revision: 19, Authorised

Entities: Levemir, Humanism
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

DUBLIN, Aug. 12, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the " " report to their offering.http://photos.prnewswire.com/prnh/20130307/600769Biological drugs are typically derived from living cells and are used in the treatment ... [Published TickerTech.com - Aug 12 2014]
Entities: Market, Drugs, Vaccine
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales

Novo Nordisk ( NVO ) reported second-quarter 2014 earnings of 48 cents per American Depository Receipt (:ADR), higher than the year-ago earnings of 44 cents.In the reported quarter, revenues increased 6% to $3.9 billion year over year. The top-line was ... [Published Yahoo! Finance - Aug 08 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Novo says Tresiba trial is ahead of schedule

Novo Nordisk A/S said that a cardiovascular outcomes study for one of its newest products, Tresiba, is proceeding ahead of schedule, raising the prospect that data could be submitted to the Food and Drug Administration in the first half of 2015 with a ... [Published MedNous - Aug 08 2014]
Entities: Tresiba, Insulin, Victoza
First reported Aug 07 2014 - Updated Aug 08 2014 - 7 reports

Novo Nordisk staying the course

Novo Nordisk finished this year’s second quarter better profit-wise than it had expected. The company finished with a before tax profit of close to 9 billion kroner, just a bit higher than the 8.9 billion kroner it had projected. The company’s pretax ... [Published Copenhagen Post - Aug 07 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

Novo Nordisk Introduces New Insulin Device to U.S. Market

Novo Nordisk has introduced the Levemir® FlexTouch® prefilled insulin delivery device to the U.S. market. The device, filled with insulin detemir [rDNA origin], the first of its kind that does not use a pushbutton extension. In a conventional insulin ... [Published Diabetes Health Magazine - Jul 27 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Embrace It. Challenge It.

I haven't always been forthright and expressive about diabetes . There were a solid 10 years of my disease which I kept under wraps, hidden from everyone I knew. I was afraid of everything-to push myself harder than I had ever before, to allow people ... [Published Diabetes Health Magazine - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Global human insulin market set to grow by 35% to 2019, says new report

24-Jul-2014North America | Healthcare ApplicationsThe expiry of biologic human insulin market drugs' patents are set to create new opportunities for biosimilar drugs, which is estimated to grow at a CAGR of 35% from 2014–2019, says a new report from ... [Published Manufacturing Chemist - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Novo Nordisk Launches Levemir (insulin detemir) FlexTouch Pen in US

On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir). FlexTouch, which has been approved in Europe since July 2011 and launched in various other regions worldwide, is Novo Nordisk’s ... [Published diaTribe - Jul 24 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Type 2

Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ... [Published HealthBoards - Jul 10 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Novo Nordisk Announces U.S. Launch of New Insulin Device Levemir® FlexTouch®

PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir® FlexTouch® (insulin detemir [rDNA origin] injection) in the United ... [Published PR Newswire: Policy & Public Interest - Jun 19 2014]

Quotes

New York, NY, August 19, 2014 --( PR.com )-- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020” the global biological drugs market is estimated at USD 1, 61,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 2, 87,139.7 million in 2020."
Research and Markets (http://www.researchandmarkets.com/research/hjz57l/biological_drugs) has announced the addition of the "Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global biological drugs market is estimated at USD 161,056.5 million in 2014 and is expected to grow at a CAGR of 10...
...CEO Lars Rebien Sørensen said "this has enabled us to shorten further the timeline towards…a potential US launch of Tresiba" which he noted is "doing well in key markets."
"We are satisfied with the financial results achieved in a challenging first half of 2014,? Novo Nordisk CEO Lars Rebien Soerensen said in the statement."

More Content

All (40) | News (26) | Reports (0) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
FDA Gives “Tentative Approval” to BI/Lilly’s in... [Published diaTribe - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 22 2014]
Biological Drugs Market Will Reach USD 2, 87,13... [Published PR.com Press Releases - Aug 19 2014]
Global Biological Drugs Market 2014 - 2020 - In... [Published Individual.com - Aug 15 2014]
Biological Drugs Market - Global Industry Analy... [Published TickerTech.com - Aug 12 2014]
Novo Nordisk's Earnings Rise on Solid Victoza, ... [Published Yahoo! Finance - Aug 08 2014]
Novo says Tresiba trial is ahead of schedule [Published MedNous - Aug 08 2014]
Novo Nordisk staying the course [Published Copenhagen Post - Aug 07 2014]
Novo Nordisk tops Q2 profit estimates, advances... [Published FirstWord Pharma - Aug 07 2014]
Novo Nordisk operating profits rise, 2014 outlo... [Published Individual.com - Aug 07 2014]
Novo Nordisk reports profit rise, progress on U... [Published Financial Express Bangladesh - Aug 07 2014]
Novo Nordisk beats estimates as net profit grow... [Published Pharma Letter - Aug 07 2014]
Novo Nordisk reports profit rise, progress on U... [Published Business Recorder - Aug 07 2014]
Novo Nordisk Profit Beats Estimates as Victoza ... [Published Washington Post - Aug 07 2014]
Novo Nordisk H1 Profit Up - Quick Facts [Published RTTNews.com - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published EuroInvestor - Aug 07 2014]
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Aug 05 2014]
Long-acting basal insulin Lantus accounts for a... [Published Live-PR.com - Jul 31 2014]
Over the next few years Lilly plans to launch o... [Published Live-PR.com - Jul 31 2014]
Novo Nordisk Introduces New Insulin Device to U... [Published Diabetes Health Magazine - Jul 27 2014]
Biological Drugs Market: Global Industry Analys... [Published PRWeb - Jul 25 2014]
New Federal Website Will Shine Light on Drug Co... [Published Government Technology US - Jul 25 2014]
Embrace It. Challenge It. [Published Diabetes Health Magazine - Jul 25 2014]
Global human insulin market set to grow by 35% ... [Published Manufacturing Chemist - Jul 24 2014]
Novo Nordisk Launches Levemir (insulin detemir)... [Published diaTribe - Jul 24 2014]
Zacks Reiterates “Neutral” Rating for Novo Nord... [Published American Banking News - Jul 23 2014]
Human Insulin Market Worth $42 Billion by 2019 ... [Published PRWeb - Jul 22 2014]
Type 2 [Published HealthBoards - Jul 10 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 22 2014]
Biological Drugs Market Will Reach USD 2, 87,13... [Published PR.com Press Releases - Aug 19 2014]
New York, NY, August 19, 2014 --( PR.com )-- Persistence Market Research (http://www.persistencemarketresearch.com) Released New Market Report on "Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020” the global biological ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Aug 05 2014]
Type 2 [Published HealthBoards - Jul 10 2014]
Found myself in ketoacidosis after being off Orals at least 1mo. Took 40u Novolog, 120u Levemir-it was available. My blood glucose is 534, extremely restless, urinating every hour, sickening sweet smell all around me, tried bathing. Plan to recheck ...
Human Insulin Market worth $42 Billion by 2018 [Published PR Newswire: General Business - Jun 27 2014]
DALLAS, June 27, 2014 /PRNewswire/ --According to the new market research report, "Human Insulin Market by Product Type (Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed), by Brand ...
1 2

Press Releases

sort by: Date | Relevance
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - Aug 07 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
Novo Nordisk A/S: Novo Nordisk increased operat... [Published GlobeNewswire: Acquisitions News - May 01 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.